Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: obstructive HCM

imaging study of the heart with scales of justice overlay balancing male and female symbols

Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling

End-of-treatment VALOR-HCM analyses reassure on use in women, suggest disease-modifying potential

Obstructive hypertrophic cardiomyopathy

REMS Update: Mavacamten Still Effective in Treating Real-World Patients With HCM

Few patients report left ventricular dysfunction or heart failure after one year

22-HVI-2769712_hyptertrophic-cardiomyopathy_650x450

Mavacamten Significantly Reduces Patients’ Need for Septal Reduction Therapy Over 16 Weeks

Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad